Ripka, Jodi

Ripka, Jodi was paid $45K by Medicaid between Oct 2022 and Jan 2023, across 12 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 37% of everything it billed.

33Billing provider infoRIPKA, JODI
HOLYOKE, MA 01040

33aNPI1013907179assigned 10/28/2005

33bProvider typePediatric Nurse Practitioner

28Total paid$45K

24GClaims747

24DCodes billed12

24AFirst – last monthOct 2022 – Jan 2023

Compared with peers

Next to other Pediatric Nurse Practitioner providers in Massachusetts

Rank by total paid#25 of 125

Median peer was paid$6K

This provider vs. median7.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	547	$33K
2023	200	$12K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	37%	123	123	$17K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	28%	110	106	$12K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	12%	107	105	$6K
90460	Immunization administration through 18 years of age via any route, first or only component	9.3%	88	88	$4K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	5.9%	32	32	$3K
90461		2.2%	30	30	$1K
S0302	Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)	2.2%	109	109	$986.45
96110	Developmental screening, with scoring and documentation, per standardized instrument	2.0%	81	78	$883.22
96127		<1%	26	26	$277.29
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	14	12	$202.30
94760		<1%	15	15	$29.70
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	12	12	$21.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.